Skip to main content
Erschienen in: Discover Oncology 2/2014

01.04.2014 | Original Paper

Analgesic Use and Patterns of Estrogen Metabolism in Premenopausal Women

verfasst von: Renée T. Fortner, Hannah Oh, Sarah E. Daugherty, Xia Xu, Susan E. Hankinson, Regina G. Ziegler, A. Heather Eliassen

Erschienen in: Discover Oncology | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Analgesic use has been hypothesized to reduce the risk of some cancers, with inverse associations between analgesics and colon cancer, and suggestive inverse associations for breast cancer. Estrogen metabolites (EM) have genotoxic and estrogenic potential; genotoxicity may differ by hydroxylation pathway. Analgesic use may impact patterns of estrogen metabolism; effects of analgesics on disease risk could be mediated through these patterns. We conducted a cross-sectional study among 603 premenopausal women in the Nurses' Health Study II. Frequency of aspirin, non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs), and acetaminophen use was reported via questionnaire; average frequency in 1997 and 1999 was calculated. Women provided urine samples between 1996 and 1999, collected during the mid-luteal phase of the menstrual cycle. Urinary EM were quantified using high-performance liquid chromatography-tandem mass spectrometry. We observed no association between analgesic use and estradiol, estrone, or specific pathways of estrogen metabolism. Women reporting more frequent aspirin use had lower methylated 2-catechols (e.g., 2-hydroxyestrone-3-methyl ether, 2+ days/week vs. non-use: 0.95 vs. 1.21 pmol/mg creatinine; p difference = 0.01, p trend = 0.07). Non-aspirin NSAID use was positively associated with 17-epiestriol (4+ days/week vs. non-use: 2.48 vs. 1.52 pmol/mg creatinine; p difference = 0.01, p trend = 0.11). Acetaminophen use was positively associated with total EM (2+ days/week vs. non-use: 236 vs. 198 pmol/mg creatinine; p difference = 0.02, p trend = 0.11), 2-hydroxyestrone-3-methyl ether (1.6 vs. 1.1 pmol/mg creatinine; p difference < 0.01, p trend = 0.02), and 16α-hydroxyestrone (17 vs. 12 pmol/mg creatinine; p difference = 0.01, p trend = 0.05). This study provides the first assessment of analgesic use and patterns of estrogen metabolism in women. While we observed some associations between analgesics and individual EM, no clear patterns emerged.
Literatur
4.
Zurück zum Zitat Dubé C, Rostom A, Lewin G et al (2007) The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med 146:365–375PubMedCrossRef Dubé C, Rostom A, Lewin G et al (2007) The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med 146:365–375PubMedCrossRef
5.
Zurück zum Zitat Rostom A, Dubé C, Lewin G et al (2007) Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med 146:376–389PubMedCrossRef Rostom A, Dubé C, Lewin G et al (2007) Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med 146:376–389PubMedCrossRef
8.
Zurück zum Zitat Eliassen AH, Chen WY, Spiegelman D et al (2009) Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and risk of breast cancer among premenopausal women in the Nurses' Health Study II. Arch Intern Med 169:115–121. discussion 121 doi: 10.1001/archinternmed.2008.537 Eliassen AH, Chen WY, Spiegelman D et al (2009) Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and risk of breast cancer among premenopausal women in the Nurses' Health Study II. Arch Intern Med 169:115–121. discussion 121 doi: 10.​1001/​archinternmed.​2008.​537
9.
Zurück zum Zitat Zhang X, Smith-Warner SA, Collins LC et al (2012) Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidence. JCO 30:3468–3477. doi:10.1200/JCO.2012.42.2006 CrossRef Zhang X, Smith-Warner SA, Collins LC et al (2012) Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidence. JCO 30:3468–3477. doi:10.​1200/​JCO.​2012.​42.​2006 CrossRef
12.
Zurück zum Zitat Key T, Appleby P, Barnes I et al (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94:606–616PubMedCrossRef Key T, Appleby P, Barnes I et al (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94:606–616PubMedCrossRef
17.
Zurück zum Zitat Xu X, Veenstra TD, Fox SD et al (2005) Measuring fifteen endogenous estrogens simultaneously in human urine by high-performance liquid chromatography-mass spectrometry. Anal Chem 77:6646–6654. doi:10.1021/ac050697c PubMedCrossRef Xu X, Veenstra TD, Fox SD et al (2005) Measuring fifteen endogenous estrogens simultaneously in human urine by high-performance liquid chromatography-mass spectrometry. Anal Chem 77:6646–6654. doi:10.​1021/​ac050697c PubMedCrossRef
18.
Zurück zum Zitat Falk RT, Xu X, Keefer L et al (2008) A liquid chromatography-mass spectrometry method for the simultaneous measurement of 15 urinary estrogens and estrogen metabolites: assay reproducibility and interindividual variability. Cancer Epidemiol Biomarkers Prev 17:3411–3418. doi:10.1158/1055-9965.EPI-08-0355 PubMedCrossRef Falk RT, Xu X, Keefer L et al (2008) A liquid chromatography-mass spectrometry method for the simultaneous measurement of 15 urinary estrogens and estrogen metabolites: assay reproducibility and interindividual variability. Cancer Epidemiol Biomarkers Prev 17:3411–3418. doi:10.​1158/​1055-9965.​EPI-08-0355 PubMedCrossRef
23.
Zurück zum Zitat Rosner B (1983) Percentage points for a generalized ESD many-outlier procedure. Technometrics 165–172. Rosner B (1983) Percentage points for a generalized ESD many-outlier procedure. Technometrics 165–172.
27.
Zurück zum Zitat Straus JF III (2004) The synthesis and metabolism of steroid hormones. In: Straus JF III, Barbieri RL (eds) Yen and Jaffe's reproductive endocrinology, 5th edn. Elsevier Saunders, Philadelphia, pp 125–154 Straus JF III (2004) The synthesis and metabolism of steroid hormones. In: Straus JF III, Barbieri RL (eds) Yen and Jaffe's reproductive endocrinology, 5th edn. Elsevier Saunders, Philadelphia, pp 125–154
Metadaten
Titel
Analgesic Use and Patterns of Estrogen Metabolism in Premenopausal Women
verfasst von
Renée T. Fortner
Hannah Oh
Sarah E. Daugherty
Xia Xu
Susan E. Hankinson
Regina G. Ziegler
A. Heather Eliassen
Publikationsdatum
01.04.2014
Verlag
Springer US
Erschienen in
Discover Oncology / Ausgabe 2/2014
Print ISSN: 1868-8497
Elektronische ISSN: 2730-6011
DOI
https://doi.org/10.1007/s12672-013-0167-5

Weitere Artikel der Ausgabe 2/2014

Discover Oncology 2/2014 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.